Pioneering the future of Dementia diagnostics
Our First Solution
A next-generation blood biomarker test for Alzheimer’s
Alzheimer’s Disease is rising fast and diagnostics options have struggled to keep pace with innovations in treatment and prevention.
SMarT Minds Dx is developing a breakthrough blood-based diagnostic that enables precision on a global scale.
Early detection of Alzheimer’s pathology
Our blood test will identify a change in an early detection biomarker shifts, giving clinicians and families more time to act, plan, and intervene proactively.
Precise staging across the disease continuum
We will provide insight into the biological stage of Alzheimer’s supporting more confident clinical decision-making.
Accurate monitoring of therapeutic response
Our technology will measure changes in amyloid and tau to support treatment optimisation and personalised care.
Affordable and scalable at population level
Our blood test will remove barriers to access and allows health systems to implement equitable screening programs without the infrastructure burden of traditional tests.
Proprietary antibodies and validated science
Developed using decades of Alzheimer’s research and advanced digital immunoassay platforms.
Seamless integration into existing pathology workflows
Fits effortlessly into standard blood collection pathways, enabling thousands of clinics and laboratories to adopt Alzheimer’s diagnostics without significant operational change.
About
We exist to change the trajectory of Dementia by making world-leading diagnostics accessible to all – not just those who can afford invasive or high-cost testing. Our work is built on scientific rigour, compassion, and the belief that early clarity changes lives.
